Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Virenc AB currently has 1 pending office action under review. The prosecution of this portfolio is handled by 1 distinct examiner, specifically VARADARAJ, ARCHANA, who is listed as the busiest examiner with 1 busiest examiner pending office action. The data shows 0 distinct art units associated with this activity. This 1 pending office action represents the current engagement with the patent office.
With 1 distinct examiner involved, the company's current patent strategy is dependent on the individual review of this official. The presence of 1 pending office action suggests a limited engagement with the patent office. Practitioners should focus on the specific tendencies of the 1 distinct examiner to navigate the current prosecution cycle for the 1 busiest examiner pending office action that matches the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VARADARAJ, ARCHANA | 1 | 80.0% | +33.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18749113 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS | VARADARAJ, ARCHANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18749113 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS | VARADARAJ, ARCHANA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18749113 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS | VARADARAJ, ARCHANA | — | §103§112DP | Non-Final OA | — | Pending | Jun 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial